Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Brian Abel

Brian Abel

Head, Immunogenomics Core
SIgN, A*STAR
Singapore

Biography

Brian Abel received his Ph.D. in 2006 at the ETH, Zurich, and thereafter conducted a postdoctoral fellowship at SATVI, University of Cape Town, where he oversaw the immunological assessment of a novel TB vaccine in clinical trials and contributed to TB biomarker discovery. Brian completed an MBA at Tel Aviv University and ISB, Hyderabad, to facilitate a transition from academia into translational roles in biomedical science. Brian joined SIgN in 2012 to manage the Immunomonitoring Platform, conducting business development, project management and supporting finalization of agreements with industry partners, as well as acquiring regulatory approval for clinical research. He is also actively involved in Platform technology development in order to keep it up to date with the latest advances in the field of Immunomonitoring. In August 2016, Brian became the Head of the Immunogenomics Core to support and drive genomic activities for SIgN's researchers and facilitate collaborations with industry partners.

Research Interest

He is actively involved in Platform technology development in order to keep it up to date with the latest advances in the field of Immunomonitoring.